Intercept to Announce Second Quarter 2021 Financial Results on July 29, 2021

Rhea-AI Summary

Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT) will disclose its second quarter 2021 financial results on July 29, 2021, before market open. This will be followed by a conference call at 8:30 a.m. ET to discuss the results. The call can be accessed through the investor section of the company's website or via phone. Intercept focuses on developing treatments for progressive non-viral liver diseases, including PBC and NASH, and has operations across the U.S., Europe, and Canada.

NEW YORK, July 19, 2021 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, will announce its second quarter 2021 financial results prior to market open on Thursday, July 29, 2021. The announcement will be followed by a conference call and audio webcast hosted by Intercept management at 8:30 a.m. ET to discuss the results.

The conference call will be available on the investor page of our website at http://ir.interceptpharma.com or by calling (855) 232-3919 (toll-free domestic) or (315) 625-6894 (international) passcode 2919379. Archived webcasts will be available on Intercept’s website for approximately two weeks.

About Intercept

Intercept is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, including primary biliary cholangitis (PBC) and nonalcoholic steatohepatitis (NASH). Founded in 2002 in New York, Intercept has operations in the United States, Europe and Canada. For more information, please visit www.interceptpharma.com or connect with the company on Twitter and LinkedIn.

CONTACT

For more information about Intercept, please contact:

Investor inquiries:  investors@interceptpharma.com

Media inquiries: media@interceptpharma.com

Source: Intercept Pharmaceuticals, Inc.

FAQ

When will Intercept Pharmaceuticals announce its Q2 2021 financial results?

Intercept Pharmaceuticals will announce its Q2 2021 financial results on July 29, 2021, prior to market open.

What time is the conference call for Intercept's Q2 2021 financial results?

The conference call for Intercept's Q2 2021 financial results is scheduled for 8:30 a.m. ET.

How can I listen to Intercept Pharmaceuticals' conference call?

You can listen to Intercept Pharmaceuticals' conference call via their investor page or by calling the provided numbers.

What diseases does Intercept Pharmaceuticals focus on?

Intercept Pharmaceuticals develops therapies for progressive non-viral liver diseases, including primary biliary cholangitis (PBC) and nonalcoholic steatohepatitis (NASH).